Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Domestic
Equity Passive

RISE Healthcare (253280)

Update : 2025.10.15

NAV

14,714KRW

-83.48하락 (-0.56%)

Market Price per share (KRW)

14,665KRW

-165하락 (-1.11%)

※ t-1 last price

trading volume

28,996shares

AUM

KRW 8.8billion

Share it

RISE Healthcare (253280)

Overview Performance Holdings

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2025.10.15
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280) 		FnGuide HealthCare Index 2016.09.23 50,000 8,828,184,243
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 14,665
※ t-1 last price 		14,713 28,996
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280) 		FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
8,828,184,243 하나은행
Market Price per share (KRW) iNAV per share (KRW)
14,665
※ t-1 last price 		14,713
Trading Volume (shares)
28,996
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2025-10-15
Rank , Name, proportion table
Rank Name Weight (%)
1 Alteogen 10.50
2 Celltrion 10.11
3 SAMSUNG BIOLOGICS 9.57
4 Yuhan 9.37
5 HLB 6.53
6 LCB 5.62
7 PharmaResearch 5.39
8 ABL Bio 4.38
9 SCD 4.00
10 SKBP 3.95

proportion by sectors

*The proportion of investment stocks

Update : 2025.10.15
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2025-10-15

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV -4.46 -0.78 10.12 -6.31 51.95 5.35 45.07
Benchmark Index -4.54 -0.79 10.48 -6.48 51.89 5.57 46.06
Outperformance 0.08 0.01 -0.37 0.17 0.06 -0.23 -1.0

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2025.10.13 14,665 -1.112하락 14,713.64 -0.564하락 10,355.02
2025.10.10 14,830 -0.835하락 14,797.2 -0.941하락 10,355.12
2025.10.02 14,955 0.673상승 14,938.1 0.545상승 10,355.44
2025.10.01 14,855 0.236상승 14,857 0.127상승 10,355.49
2025.09.30 14,820 -0.636하락 14,838.01 -0.648하락 10,355.53
2025.09.29 14,915 0.913상승 14,934.92 1.097상승 10,355.56
2025.09.26 14,780 -1.956하락 14,772.83 -1.775하락 10,354.31
2025.09.25 15,075 -1.759하락 15,039.92 -2.061하락 10,354.34
2025.09.24 15,345 -2.323하락 15,356.51 -2.308하락 10,354.38
2025.09.23 15,710 0.351상승 15,719.36 0.384상승 10,354.41
2025.09.22 15,655 2.186상승 15,659.13 1.811상승 10,354.44
2025.09.19 15,320 1.222상승 15,380.52 1.518상승 10,354.54
2025.09.18 15,135 0.099상승 15,150.49 0.422상승 10,354.57
2025.09.17 15,120 -1.530하락 15,086.68 -1.529하락 10,354.6
2025.09.16 15,355 0.032상승 15,321.01 -0.403하락 10,354.64
2025.09.15 15,350 -0.357하락 15,383.09 -0.108하락 10,354.67

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 Alteogen KR7196170005 174 10.5 77,256,000
2 Celltrion KR7068270008 435 10.11 74,341,500
3 SAMSUNG BIOLOGICS KR7207940008 69 9.57 70,380,000
4 Yuhan KR7000100008 582 9.37 68,908,800
5 HLB KR7028300002 1,220 6.53 48,007,000
6 LCB KR7141080002 273 5.62 41,332,200
7 PharmaResearch KR7214450009 71 5.39 39,689,000
8 ABL Bio KR7298380007 352 4.38 32,208,000
9 SCD KR7000250001 145 4 29,435,000
10 SKBP KR7326030004 284 3.95 29,081,600
11 HanmiPharm KR7128940004 66 3.13 23,034,000
12 Hugel KR7145020004 55 2 14,740,000
13 원화예금 KRD010010001 13,892,550 1.89 13,892,550
14 HANALL BIOPHARMA KR7009420001 368 1.73 12,696,000
15 SKBS KR7302440003 276 1.72 12,682,200
16 ST Pharm KR7237690003 131 1.68 12,353,300
17 Celltrionph KR7068760008 210 1.51 11,130,000
18 CLASSYS KR7214150005 182 1.19 8,745,100
19 L&C BIO KR7290650001 173 1.17 8,632,700
20 SEEGENE KR7096530001 334 1.12 8,216,400
21 Hanmi Science KR7008930000 212 1.05 7,748,600
22 GC Corp KR7006280002 57 1 7,381,500
23 Pharmicell KR7005690003 583 0.99 7,270,010
24 MedyTox KR7086900008 57 0.92 6,794,400
25 HK inno.N KR7195940002 148 0.92 6,748,800
26 DAEWOONG PHARM KR7069620003 47 0.86 6,293,300
27 CHA Biotech KR7085660009 556 0.84 6,210,520
28 Binex KR7053030003 300 0.66 4,878,000
29 DongKook Pharm KR7086450004 244 0.62 4,538,400
30 ShinpoongPharm KR7019170000 345 0.6 4,381,500
31 EuBio KR7206650004 324 0.57 4,176,360
32 WONTECH KR7336570007 448 0.55 4,076,800
33 HLBPHARMA KR7047920004 290 0.53 3,917,900
34 DENTIUM KR7145720009 69 0.51 3,732,900
35 SD Biosensor KR7137310009 364 0.48 3,519,880
36 SELVAS AI KR7108860008 247 0.48 3,509,870
37 BIONEER KR7064550007 231 0.42 3,063,060
38 CUREXO KR7060280005 302 0.41 3,050,200
39 BioPlus KR7099430001 432 0.38 2,812,320
40 Huons Global KR7084110006 57 0.34 2,505,150
41 T&L KR7340570001 48 0.31 2,311,200
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.